VLA1553 + Control
Phase 3Withdrawn 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Chikungunya Virus Infection
Conditions
Chikungunya Virus Infection
Trial Timeline
Feb 6, 2026 → Nov 1, 2027
NCT ID
NCT07133178About VLA1553 + Control
VLA1553 + Control is a phase 3 stage product being developed by Valneva SE for Chikungunya Virus Infection. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT07133178. Target conditions include Chikungunya Virus Infection.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07133178 | Phase 3 | Withdrawn |
Competing Products
20 competing products in Chikungunya Virus Infection